[{"id":"e2019c9b-caf1-4a03-a256-ccdcd1f5cf7b","acronym":"","url":"https://clinicaltrials.gov/study/NCT06287528","created_at":"2024-03-01T19:33:07.907Z","updated_at":"2025-02-25T13:50:10.638Z","phase":"Phase 1","brief_title":"A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)","source_id_and_acronym":"NCT06287528","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" IL18","pipe":"","alterations":" ","tags":["IL18"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 02/23/2024","start_date":" 02/23/2024","primary_txt":" Primary completion: 02/23/2028","primary_completion_date":" 02/23/2028","study_txt":" Completion: 02/23/2028","study_completion_date":" 02/23/2028","last_update_posted":"2025-02-20"},{"id":"ad67aba0-0a78-4409-a9da-54568d0c4622","acronym":"","url":"https://clinicaltrials.gov/study/NCT06505356","created_at":"2025-02-27T07:48:10.382Z","updated_at":"2025-02-27T07:48:10.382Z","phase":"","brief_title":"Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association With Disease Stage","source_id_and_acronym":"NCT06505356","lead_sponsor":"Edgaras Burzinskis","biomarkers":" IFNG • IL6 • TNFA • IL2 • IL10 • CCL19 • IL18 • CTBP2 • GAS5 • JAZF1","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • IL2 • IL10 • CCL19 • IL18 • CTBP2 • GAS5 • JAZF1"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 400","initiation":"Initiation: 09/01/2024","start_date":" 09/01/2024","primary_txt":" Primary completion: 08/30/2028","primary_completion_date":" 08/30/2028","study_txt":" Completion: 08/30/2028","study_completion_date":" 08/30/2028","last_update_posted":"2024-07-17"},{"id":"c1b27e69-5cb6-4c7f-a2c7-df42fb2ed239","acronym":"CYTOK-AZA","url":"https://clinicaltrials.gov/study/NCT06439199","created_at":"2024-06-08T04:34:20.475Z","updated_at":"2024-07-02T16:34:59.405Z","phase":"","brief_title":"Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy","source_id_and_acronym":"NCT06439199 - CYTOK-AZA","lead_sponsor":"Nantes University Hospital","biomarkers":" IL6 • TNFA • CXCL8 • IL10 • CSF2 • IL18 • IL17A • IL15 • IL1B","pipe":"","alterations":" ","tags":["IL6 • TNFA • CXCL8 • IL10 • CSF2 • IL18 • IL17A • IL15 • IL1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e azacitidine"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 06/15/2024","start_date":" 06/15/2024","primary_txt":" Primary completion: 04/15/2026","primary_completion_date":" 04/15/2026","study_txt":" Completion: 12/15/2026","study_completion_date":" 12/15/2026","last_update_posted":"2024-06-03"},{"id":"6d75ad4c-058e-423c-b18e-d76a606eee1c","acronym":"","url":"https://clinicaltrials.gov/study/NCT06063486","created_at":"2023-10-02T19:12:41.881Z","updated_at":"2024-07-02T16:35:08.684Z","phase":"Phase 2","brief_title":"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","source_id_and_acronym":"NCT06063486","lead_sponsor":"University of Southern California","biomarkers":" IL6 • TNFA • IL18","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL18"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 03/01/2024","start_date":" 03/01/2024","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 03/01/2027","study_completion_date":" 03/01/2027","last_update_posted":"2024-04-19"},{"id":"6db954e8-43a6-4f85-805a-10d3f605b83c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05783570","created_at":"2023-03-24T16:04:17.343Z","updated_at":"2024-07-02T16:35:14.560Z","phase":"Phase 1","brief_title":"To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307","source_id_and_acronym":"NCT05783570","lead_sponsor":"Eutilex","biomarkers":" IFNG • IL6 • TNFA • GPC3 • IL2 • IL10 • IL18","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • GPC3 • IL2 • IL10 • IL18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EU307"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 08/24/2023","start_date":" 08/24/2023","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-03-15"},{"id":"516a1481-2de8-44ea-b356-947a33ffc479","acronym":"","url":"https://clinicaltrials.gov/study/NCT06017258","created_at":"2023-08-30T14:08:49.071Z","updated_at":"2024-07-02T16:35:22.406Z","phase":"Phase 1","brief_title":"A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia","source_id_and_acronym":"NCT06017258","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" FLT3 • IDH1 • IDH2 • IL18 • CD37","pipe":" | ","alterations":" FLT3-ITD mutation • IDH1 mutation • IDH2 mutation • CD37 expression","tags":["FLT3 • IDH1 • IDH2 • IL18 • CD37"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3-ITD mutation • IDH1 mutation • IDH2 mutation • CD37 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD371-YSNVZ-IL18 CAR T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 6","initiation":"Initiation: 08/22/2023","start_date":" 08/22/2023","primary_txt":" Primary completion: 08/22/2026","primary_completion_date":" 08/22/2026","study_txt":" Completion: 08/22/2026","study_completion_date":" 08/22/2026","last_update_posted":"2024-01-24"},{"id":"09b806b7-5ada-4ec4-bf5b-2c8ce1a24629","acronym":"BACCARAT","url":"https://clinicaltrials.gov/study/NCT02605512","created_at":"2022-06-04T15:45:36.960Z","updated_at":"2024-07-02T16:35:29.944Z","phase":"","brief_title":"BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study","source_id_and_acronym":"NCT02605512 - BACCARAT","lead_sponsor":"Sophie JACOB","biomarkers":" IL6 • CD14 • MIR34A • IL18 • CD31 • MIR17 • MIR182 • MIR18A • PECAM1 • CRP • ITGA2B • MIR140 • MIR145 • MIR150 • MIR22 • MIR423","pipe":"","alterations":" ","tags":["IL6 • CD14 • MIR34A • IL18 • CD31 • MIR17 • MIR182 • MIR18A • PECAM1 • CRP • ITGA2B • MIR140 • MIR145 • MIR150 • MIR22 • MIR423"],"overall_status":"Completed","enrollment":" Enrollment 118","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 02/01/2020","primary_completion_date":" 02/01/2020","study_txt":" Completion: 02/01/2020","study_completion_date":" 02/01/2020","last_update_posted":"2023-11-08"},{"id":"a03d3af5-bc9a-495c-a3cf-cca5e665a5f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT06082362","created_at":"2023-10-14T01:13:16.661Z","updated_at":"2024-07-02T16:35:33.610Z","phase":"","brief_title":"Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men","source_id_and_acronym":"NCT06082362","lead_sponsor":"IRCCS San Raffaele","biomarkers":" CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1","pipe":"","alterations":" ","tags":["CD8 • CD4 • IL18 • IL1B • NLRP3 • CASP1"],"overall_status":"Recruiting","enrollment":" Enrollment 350","initiation":"Initiation: 06/21/2023","start_date":" 06/21/2023","primary_txt":" Primary completion: 06/20/2024","primary_completion_date":" 06/20/2024","study_txt":" Completion: 06/20/2025","study_completion_date":" 06/20/2025","last_update_posted":"2023-10-13"},{"id":"fb8dc3ab-b4a9-4b4d-aae6-7233509f61b6","acronym":"Neo Combi","url":"https://clinicaltrials.gov/study/NCT01972347","created_at":"2021-03-01T20:52:35.949Z","updated_at":"2024-07-02T16:35:38.660Z","phase":"Phase 2","brief_title":"Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma","source_id_and_acronym":"NCT01972347 - Neo Combi","lead_sponsor":"Melanoma Institute Australia","biomarkers":" EGFR • CD20 • CD8 • PD-1 • CCND1 • MCL1 • IL6 • CTNNB1 • TNFA • CD163 • CD4 • IL10 • CD68 • IL18 • FOXP3 • CDKN1A","pipe":" | ","alterations":" BRAF mutation • BRAF V600","tags":["EGFR • CD20 • CD8 • PD-1 • CCND1 • MCL1 • IL6 • CTNNB1 • TNFA • CD163 • CD4 • IL10 • CD68 • IL18 • FOXP3 • CDKN1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation • BRAF V600"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Mekinist (trametinib) • Tafinlar (dabrafenib)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 35","initiation":"Initiation: 10/01/2014","start_date":" 10/01/2014","primary_txt":" Primary completion: 05/04/2017","primary_completion_date":" 05/04/2017","study_txt":" Completion: 05/01/2024","study_completion_date":" 05/01/2024","last_update_posted":"2023-08-30"},{"id":"c15a52de-3419-47f0-9b51-09f2e18386cc","acronym":"","url":"https://clinicaltrials.gov/study/NCT05964985","created_at":"2023-07-31T17:08:51.096Z","updated_at":"2024-07-02T16:35:41.679Z","phase":"","brief_title":"Effect of Quadratus Lumborum Block With Compound Lidocaine and Esketamine on Pain After Colorectal Surgery","source_id_and_acronym":"NCT05964985","lead_sponsor":"Tianjin Medical University General Hospital","biomarkers":" CCL2 • IL18 • IL17A • IL23A • CXCL1","pipe":"","alterations":" ","tags":["CCL2 • IL18 • IL17A • IL23A • CXCL1"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 160","initiation":"Initiation: 08/06/2023","start_date":" 08/06/2023","primary_txt":" Primary completion: 01/15/2024","primary_completion_date":" 01/15/2024","study_txt":" Completion: 02/15/2024","study_completion_date":" 02/15/2024","last_update_posted":"2023-07-28"},{"id":"95d0b020-45e1-46fb-b139-70c1335994d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT05963334","created_at":"2023-07-27T17:08:59.436Z","updated_at":"2024-07-02T16:35:41.710Z","phase":"Phase 1/2","brief_title":"Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer","source_id_and_acronym":"NCT05963334","lead_sponsor":"Cairo University","biomarkers":" CEACAM5 • IL18 • KIM1 • LCN2","pipe":"","alterations":" ","tags":["CEACAM5 • IL18 • KIM1 • LCN2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel"],"overall_status":"Completed","enrollment":" Enrollment 49","initiation":"Initiation: 01/01/2015","start_date":" 01/01/2015","primary_txt":" Primary completion: 11/30/2019","primary_completion_date":" 11/30/2019","study_txt":" Completion: 06/06/2023","study_completion_date":" 06/06/2023","last_update_posted":"2023-07-27"},{"id":"1d18300f-96b0-420a-b04e-dbe68d19b1eb","acronym":"","url":"https://clinicaltrials.gov/study/NCT05959265","created_at":"2023-07-27T18:08:39.101Z","updated_at":"2024-07-02T16:35:42.099Z","phase":"","brief_title":"Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung Cancer","source_id_and_acronym":"NCT05959265","lead_sponsor":"The First Affiliated Hospital of Guangzhou Medical University","biomarkers":" IL2 • IL18","pipe":"","alterations":" ","tags":["IL2 • IL18"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 180","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 08/01/2025","study_completion_date":" 08/01/2025","last_update_posted":"2023-07-25"},{"id":"d11ffaef-a881-4b92-8b17-ce6fd84f7ffc","acronym":"","url":"https://clinicaltrials.gov/study/NCT03889093","created_at":"2021-01-18T19:09:56.189Z","updated_at":"2024-07-02T16:36:01.580Z","phase":"","brief_title":"Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System","source_id_and_acronym":"NCT03889093","lead_sponsor":"University of Minnesota","biomarkers":" IL6 • IL2 • IL10 • IL18","pipe":"","alterations":" ","tags":["IL6 • IL2 • IL10 • IL18"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/09/2018","start_date":" 08/09/2018","primary_txt":" Primary completion: 06/01/2023","primary_completion_date":" 06/01/2023","study_txt":" Completion: 06/01/2024","study_completion_date":" 06/01/2024","last_update_posted":"2022-10-31"},{"id":"b0eb940c-240b-420a-b995-ea0878dc07ac","acronym":"","url":"https://clinicaltrials.gov/study/NCT04540224","created_at":"2021-01-18T21:43:28.301Z","updated_at":"2024-07-02T16:36:05.814Z","phase":"","brief_title":"The Relationship Between the Differences in Blood Cytokine Values in Breast Cancers.","source_id_and_acronym":"NCT04540224","lead_sponsor":"Istanbul Training and Research Hospital","biomarkers":" IL6 • CXCL8 • IL10 • IL18 • IL17A • IL23A • IL33","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL10 • IL18 • IL17A • IL23A • IL33"],"overall_status":"Completed","enrollment":" Enrollment 78","initiation":"Initiation: 08/01/2020","start_date":" 08/01/2020","primary_txt":" Primary completion: 12/01/2021","primary_completion_date":" 12/01/2021","study_txt":" Completion: 05/01/2022","study_completion_date":" 05/01/2022","last_update_posted":"2022-08-09"},{"id":"5a88e172-f3f1-4d49-981a-f074496e0ad9","acronym":"","url":"https://clinicaltrials.gov/study/NCT05122338","created_at":"2021-11-16T12:53:42.048Z","updated_at":"2024-07-02T16:36:20.673Z","phase":"","brief_title":"Effect of Transversus Abdominis Plane Block With Compound Lidocaine and Esketamine on Pain After Surgery","source_id_and_acronym":"NCT05122338","lead_sponsor":"Tianjin Medical University General Hospital","biomarkers":" CCL2 • IL18 • IL17A • IL23A • CXCL1","pipe":"","alterations":" ","tags":["CCL2 • IL18 • IL17A • IL23A • CXCL1"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 160","initiation":"Initiation: 12/01/2021","start_date":" 12/01/2021","primary_txt":" Primary completion: 05/15/2022","primary_completion_date":" 05/15/2022","study_txt":" Completion: 06/15/2022","study_completion_date":" 06/15/2022","last_update_posted":"2021-11-16"},{"id":"44b23d2a-b087-4118-a03c-973d0274971d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03753399","created_at":"2021-01-18T18:27:13.189Z","updated_at":"2024-07-02T16:36:29.974Z","phase":"","brief_title":"Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study","source_id_and_acronym":"NCT03753399","lead_sponsor":"Guangzhou University of Traditional Chinese Medicine","biomarkers":" CD8 • IFNG • IL6 • TNFA • CXCL12 • IL2 • IL10 • CCL4 • FGF • IL18 • IL17A • IL23A • IFNA1 • IL1B • IL21 • IL22 • BDNF","pipe":"","alterations":" ","tags":["CD8 • IFNG • IL6 • TNFA • CXCL12 • IL2 • IL10 • CCL4 • FGF • IL18 • IL17A • IL23A • IFNA1 • IL1B • IL21 • IL22 • BDNF"],"overall_status":"Completed","enrollment":" Enrollment 66","initiation":"Initiation: 01/04/2019","start_date":" 01/04/2019","primary_txt":" Primary completion: 04/27/2020","primary_completion_date":" 04/27/2020","study_txt":" Completion: 04/27/2020","study_completion_date":" 04/27/2020","last_update_posted":"2021-05-20"},{"id":"0be9bf7d-9d02-4af0-bb3f-96dee38d0cfc","acronym":"","url":"https://clinicaltrials.gov/study/NCT03570541","created_at":"2021-01-18T17:34:14.170Z","updated_at":"2024-07-02T16:36:35.994Z","phase":"Phase 4","brief_title":"TQL-block for Laparoscopic Hemicolectomy","source_id_and_acronym":"NCT03570541","lead_sponsor":"Zealand University Hospital","biomarkers":" IL6 • TNFA • IL10 • GZMB • IL18 • IL17A • IL15 • IL1B • IL22","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL10 • GZMB • IL18 • IL17A • IL15 • IL1B • IL22"],"overall_status":"Completed","enrollment":" Enrollment 69","initiation":"Initiation: 06/28/2018","start_date":" 06/28/2018","primary_txt":" Primary completion: 12/05/2020","primary_completion_date":" 12/05/2020","study_txt":" Completion: 01/03/2021","study_completion_date":" 01/03/2021","last_update_posted":"2021-01-15"},{"id":"ef425926-42f5-4d8d-a884-e09be15151f7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03611985","created_at":"2021-01-18T17:45:14.355Z","updated_at":"2024-07-02T16:36:51.394Z","phase":"Phase 1/2","brief_title":"Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients","source_id_and_acronym":"NCT03611985","lead_sponsor":"University of Florida","biomarkers":" VEGFA • IL18","pipe":"","alterations":" ","tags":["VEGFA • IL18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • docetaxel"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 03/01/2020","start_date":" 03/01/2020","primary_txt":" Primary completion: 03/01/2023","primary_completion_date":" 03/01/2023","study_txt":" Completion: 03/01/2023","study_completion_date":" 03/01/2023","last_update_posted":"2020-01-13"},{"id":"52bb5c5d-556a-45d3-8898-dea38d69712f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02363491","created_at":"2021-01-18T11:15:06.236Z","updated_at":"2024-07-02T16:37:03.441Z","phase":"Phase 1/2","brief_title":"A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome","source_id_and_acronym":"NCT02363491","lead_sponsor":"Opsona Therapeutics Ltd.","biomarkers":" IFNG • IL6 • TNFA • IL10 • IL18 • IL23A • IL1B","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • IL10 • IL18 • IL23A • IL1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tomaralimab (NM-101)"],"overall_status":"Completed","enrollment":" Enrollment 96","initiation":"Initiation: 01/01/2015","start_date":" 01/01/2015","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 12/01/2018","study_completion_date":" 12/01/2018","last_update_posted":"2019-01-28"},{"id":"c9c7fea3-7791-4080-9a22-7fbd5d0d8309","acronym":"","url":"https://clinicaltrials.gov/study/NCT02746432","created_at":"2021-01-18T13:27:20.104Z","updated_at":"2024-07-02T16:37:18.607Z","phase":"Phase 4","brief_title":"Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial","source_id_and_acronym":"NCT02746432","lead_sponsor":"King Saud University","biomarkers":" IFNG • IL6 • CXCL8 • CD4 • IL10 • IL18 • TGFB1 • CCL3 • IL1B","pipe":"","alterations":" ","tags":["IFNG • IL6 • CXCL8 • CD4 • IL10 • IL18 • TGFB1 • CCL3 • IL1B"],"overall_status":"Unknown status","enrollment":" Enrollment 144","initiation":"Initiation: 01/01/2018","start_date":" 01/01/2018","primary_txt":" Primary completion: 03/01/2021","primary_completion_date":" 03/01/2021","study_txt":" Completion: 03/01/2021","study_completion_date":" 03/01/2021","last_update_posted":"2017-08-22"}]